UAMS Performs Groundbreaking Epilepsy Surgery as Part of FDA-Approved Clinical Trial
June 17, 2025
June 17, 2025
LITTLE ROCK, Arkansas, June 17 -- The University of Arkansas for Medical Sciences issued the following news release:
* * *
UAMS Performs Groundbreaking Epilepsy Surgery as Part of FDA-Approved Clinical Trial
By Linda Satter
Surgeons from the University of Arkansas for Medical Sciences (UAMS) have performed the first transplantation in Arkansas of interneuron cell therapy, called NRTX-1001, into a patient with non-lesional epilepsy as part of an . . .
* * *
UAMS Performs Groundbreaking Epilepsy Surgery as Part of FDA-Approved Clinical Trial
By Linda Satter
Surgeons from the University of Arkansas for Medical Sciences (UAMS) have performed the first transplantation in Arkansas of interneuron cell therapy, called NRTX-1001, into a patient with non-lesional epilepsy as part of an . . .